Mays Cancer Center led studies of innovative breast cancer drug that...

The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was the lead site for a study evaluating Phase I and Phase III clinical trials for elacestrant, a treatment for...(PRWeb February 01, 2023)Read the full story at https://www.prweb.com/releases/mays_cancer_center_led_studies_of_innovative_breast_cancer_drug_that_recently_gained_fda_approval/prweb19145026.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news